Summary. The amylo-1,6-glucosidase activity of human seminal plasma was studied using its specific substrate, \g=a\-glucosylSchardinger dextrin. The enzyme activity of semen is predominantly associated with the seminal plasma and proceeds at maximum velocity at pH 5\m=.\8to 6\m=.\0.
INTRODUCTION
Human seminal plasma has been shown to contain amylase (Karassik, 1927) and maltase (Sheth & Rao, 1962a, b) . Both these enzymes are known to be involved in glycogen metabolism. Amylo-l,6-glucosidase has been shown to play an important rôle in glycogen degradation. It was, therefore, of interest to find out whether amylo-l,6-glucosidase was present in human semen and whether the level of the enzyme is of metabolic or pathological significance.
MATERIALS AND METHODS
Semen samples were obtained from fertile donors and from persons referred to our laboratory by the infertility clinic of the K.E.M. Hospital. The seminal plasma was separated from spermatozoa by centrifuging the semen at 300 g for 30 min. The plasma was stored at -18°C and used when required.
Amylo-l,6-glucosidase activity was estimated according to the method of Taylor & Whelan (1966) . The substrate, Schardinger -dextrin to which an -glucose unit is attached in 1,6-linkage, was kindly made available by Dr W. J. Whelan (U.S.A.) . It has been demonstrated that amylo-l,6-glucosidase degrades the substrate to form glucose and Schardinger -dextrin. Amylo-1,6-glucosidase activity of semen was assayed by measuring glucose production using the glucose oxidase method as described previously (Gunaga, Sheth & Rao, 1967 (Harvey, 1957 (Sheth & Rao, 1962a) .
The results of the present investigations have revealed that the amylo-1,6-glucosidase present in human semen was mostly contributed by the seminal vesicular and testicular secretions. The secretions of the prostatic gland and the first portion of a split ejaculate exhibited very low enzyme activity. It was shown earlier by us that seminal maltase, another enzyme which is responsible for the glycogen degradation, was mainly contributed by the prostate.
Recent studies have indicated that both amylo-1,6-glucosidase and maltase activities of human semen increase with androgen therapy (Gunaga, Sheth, Rao & Pardanani, 1969) .
